Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.
The Covid-19 pandemic, which consumed every moment of our waking days and claimed over 1 million lives in the U.S.…
The Covid-19 pandemic, which consumed every moment of our waking days and claimed over 1 million lives in the U.S.…
Source: Bloomberg, 4:27 www.bloomberg.com #Stock #Movers #Intel #Moderna #Monday.com #Podcast
Source: Bloomberg, 4:20 www.bloomberg.com #Stock #Movers #Lumentum #Moderna #Sony #Podcast
Moderna (MRNA) stock pushed meaningfully higher on Friday following reports that the biotech giant is leveraging its mRNA platform to…
Moderna Inc. agreed to pay $950 million to settle all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH…
Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal…
The pharmaceutical giant expressed optimism that its new flu shot would be available this year, after approval concerns. Listen to…
The United States Food and Drug Administration (FDA) has refused to review Moderna’s application for approval of a flu vaccine,…
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024.…
Behind the household COVID-19 name, Moderna, is facing a $5 billion patent-infringement lawsuit over vaccine technology. On February 2, 2026,…